CClinicalTrials.gg
CompletedNCT03333577Updated Apr 30, 2019Results posted

Evaluation of the Baha SoundArc in Pediatric Patients

An interventional study of SoundArc in Hearing Loss, Conductive, Hearing Loss, Mixed and Hearing Loss, Unilateral, sponsored by Cochlear. Completed at 3 sites in United States. Open to participants aged 5 Years to 12 Years. Per ClinicalTrials.gov, last updated 2019-04-30.

Sponsored by Cochlear · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
32
Allocation
Not applicable
Ages
5 Years to 12 Years
Sex
All
01

Study summary

The purpose of this study is to gather clinical performance data on the Baha SoundArc

Read the detailed description

Current Baha recipients that are using a Baha SoftBand will be recruited to be fitted with an alternative non-surgical option for using their Baha Sound Processor. The subjects will be tested with there existing Baha Sound Processor on the SoftBand and will then be fitted with the Baha SoundArc where they will perform a one month take home trial. At the end of this trial, the subject will return for testing and evaluation of their experience with this new fitting option.

02

Conditions studied

03

Who can participate

Ages eligible
5 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:• Existing recipients using a Baha sound processor on a Softband for at least three months

  • Subjects aged 5 through 12 years of age
  • Subjects should be able to perform clinical testing adapted for age and developmental status, (Threshold sound field audiometry and basic monosyllabic word test, PBK)
  • Willingness on behalf of the subject's parent or guardian to complete study questionnaire

Exclusion Criteria:• Subject's inability to perform requisite test measures as described in the study protocol

-

04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
32 participants (actual)

Study arms

  • Experimental
    Experimental SoundArc study group

    all subjects will receive the SoundArc intervention

    Device: SoundArc

Interventions

  • DeviceSoundArc

    non-surgical attachment method for wearing a bone conduction hearing system

05

What researchers measure

Primary outcomes

  1. Patient Satisfaction Survey

    To evaluate patient experience when using the Baha SoundArc after a one month take-home trial, compared to the existing Baha Softband on the Participant Take Home questionnaire (strongly agree, Agree, Neutral, disagree, strongly disagree)

    Time frame: one month post fitting

  2. Percentage Correct on Word Identification Task

    one list of monosyllabic words (PBK words) was assessed at 60dBA, with word scores recorded as a percent correct.

    Time frame: 4 weeks post fitting

06

Results

Posted Apr 11, 2019

Participant flow

Participant flow — Overall Study
MilestoneExperimental SoundArc Study Group
Started32
Completed25
Not completed7

Outcome measures

PrimaryPatient Satisfaction Survey

To evaluate patient experience when using the Baha SoundArc after a one month take-home trial, compared to the existing Baha Softband on the Participant Take Home questionnaire (strongly agree, Agree, Neutral, disagree, strongly disagree)

Time frame:
one month post fitting
Reported as:
Number · percentage of satisfied subjects
Patient Satisfaction Survey
percentage of satisfied subjectsExperimental SoundArc Study Group
Patient Satisfaction Survey65
PrimaryPercentage Correct on Word Identification Task

one list of monosyllabic words (PBK words) was assessed at 60dBA, with word scores recorded as a percent correct.

Time frame:
4 weeks post fitting
Reported as:
Mean · % corrrect words
Percentage Correct on Word Identification Task
% corrrect wordsExperimental SoundArc Study Group
Percentage Correct on Word Identification Task85.1 ± 13.6

Adverse events

Collected over Study duration use one month interval. Adverse events were recorded from time of consent/enrollment until completion of study. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Experimental SoundArc Study Group0/25 (0%)0/25 (0%)1/25 (4%)
Most frequent other events
Most frequent other events
EventExperimental SoundArc Study Group
irritation from use of DeviceMusculoskeletal and connective tissue disorders1/25

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Experimental SoundArc Study Group
<=18 years25
Between 18 and 65 years0
>=65 years0
Sex: Female, Male
Sex: Female, Male(Participants)Experimental SoundArc Study Group
Female9
Male16
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)Experimental SoundArc Study Group
07

Study locations

3 sites
  • Arizona Hearing and Balance
    Chandler, Arizona 85224, United States
  • Rady Children's Hospital
    San Diego, California 92123, United States
  • Cook Children's Hospital
    Fort Worth, Texas 76104, United States
08

References and documents

Study documents

  • Study protocol · Aug 18, 2017

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

09

Registry details

Key details

Study ID
NCT03333577
Lead sponsor
Cochlear
Responsible party
Sponsor
First posted
Nov 7, 2017
Start date
Nov 2, 2017
Primary completion
Nov 2, 2018
Completion
Nov 2, 2018
Results posted
Apr 11, 2019
Last update
Apr 30, 2019

Study contacts

George Cire
study director · Study Director

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion